Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop (2017)

Chapter: 4 Regulatory and Reimbursement Considerations

Previous Chapter: 3 Exploring the State of the Science
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 29.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 30.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 31.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 32.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 33.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 34.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 35.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.

There was a problem loading page 36.

Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 29
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 30
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 31
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 32
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 33
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 34
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 35
Suggested Citation: "4 Regulatory and Reimbursement Considerations." National Academies of Sciences, Engineering, and Medicine. 2017. Developing Multimodal Therapies for Brain Disorders: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/23657.
Page 36
Next Chapter: 5 Trial Designs to Establish Efficacy and Safety in Multimodal Therapies
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.